CDKN2A and head and neck squamous cell carcinoma: However, HR-HPV DNA was additionally detected in 3/19 OPSCC (15.8%) with p16-negativity of the primary lesion (specificity 84.2% in OPSCC, 85.4% including HPV-driven HNSCC; Table 2).